GRI-0621, an experimental oral therapy from GRI Bio, boosts lung function in adults with IPF, according to top-line clinical ...

Columnist Sam Kirton has wonderful memories of holiday presents, but the greatest gift he's received came in the form of a lung transplant.

Caring for someone you love is intimate, humbling, and grounding, writes columnist Ann Reynoso, who swapped caregiver roles with her husband.

In her columns debut, Kylene Henderson shares how her family learned to work together after her husband's pulmonary fibrosis diagnosis.

Building on positive Phase 2 data, Puretech plans to launch a Phase 3 trial to further evaluate its experimental IPF therapy ...

Remembering loved ones who have passed invites waves of grief, but for columnist Sam Kirton, there is also joy to be found in the memories.

Bionews, Inc., the parent company of this site, has partnered with the following nonprofit advocacy organizations to help further the mission of ensuring that patients and caregivers are able to get ...

Columnist Samuel Kirton shares his emergency "go bag" checklist of things he brought when he received a bilateral lung transplant.

As my husband Donnie’s diagnosis of pulmonary fibrosis (PF) slowly unfolded, I found myself oscillating between anger, sorrow, and disbelief. At the time his symptoms appeared, he was only in his 30s.

The U.S. Food and Drug Administration (FDA) recently granted orphan drug designation to Calluna Pharma‘s CAL101 as a potential treatment for idiopathic pulmonary fibrosis (IPF). This designation is ...

What is Jascayd for idiopathic pulmonary fibrosis? Jascayd (nerandomilast) is an approved oral therapy that’s intended to slow lung function decline in adults with idiopathic pulmonary fibrosis (IPF).